Biodexa Pharmaceuticals Plc (BDRX)
2.45
-0.03
(-1.19%)
USD |
NASDAQ |
Nov 09, 16:00
2.48
+0.03
(+1.22%)
After-Hours: 19:29
Biodexa Pharmaceuticals Total Return Level : 2.480 for Nov. 6, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| November 06, 2026 | 2.480 |
| November 05, 2026 | 2.41 |
| November 04, 2026 | 2.69 |
| November 03, 2026 | 2.82 |
| November 02, 2026 | 2.80 |
| October 30, 2026 | 3.43 |
| October 29, 2026 | 3.90 |
| October 28, 2026 | 4.14 |
| October 27, 2026 | 3.93 |
| October 26, 2026 | 3.69 |
| October 23, 2026 | 3.386 |
| October 22, 2026 | 3.312 |
| October 21, 2026 | 3.359 |
| October 20, 2026 | 3.084 |
| October 19, 2026 | 3.125 |
| October 16, 2026 | 3.649 |
| October 15, 2026 | 3.451 |
| October 14, 2026 | 3.879 |
| October 13, 2026 | 2.802 |
| October 12, 2026 | 3.066 |
| October 09, 2026 | 3.682 |
| October 08, 2026 | 4.190 |
| October 07, 2026 | 4.510 |
| October 06, 2026 | 4.761 |
| October 05, 2026 | 4.914 |
| Date | Value |
|---|---|
| October 02, 2026 | 4.959 |
| October 01, 2026 | 5.061 |
| September 30, 2026 | 5.249 |
| September 29, 2026 | 5.161 |
| September 28, 2026 | 5.437 |
| September 25, 2026 | 5.408 |
| September 24, 2026 | 5.40 |
| September 23, 2026 | 5.515 |
| September 22, 2026 | 5.448 |
| September 21, 2026 | 5.439 |
| September 18, 2026 | 5.84 |
| September 17, 2026 | 6.399 |
| September 16, 2026 | 7.68 |
| September 15, 2026 | 10.64 |
| September 14, 2026 | 8.96 |
| September 11, 2026 | 10.40 |
| September 10, 2026 | 5.281 |
| September 09, 2026 | 6.498 |
| September 08, 2026 | 6.646 |
| September 04, 2026 | 6.784 |
| September 03, 2026 | 6.387 |
| September 02, 2026 | 6.279 |
| September 01, 2026 | 6.246 |
| August 31, 2026 | 6.494 |
| August 28, 2026 | 6.945 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| NuCana Plc | 0.9377 |
| Mereo BioPharma Group Plc | 0.283 |
| BioNTech SE | 88.69 |
| Silence Therapeutics Plc | 6.355 |
| Autolus Therapeutics Plc | 1.28 |